SPRY4 and central nervous system cancer: Another study revealed that the expression level of the lncRNA SPRY4-IT1 in human glioma tissues and cell lines is upregulated and SPRY4-IT1 can suppress cell growth and metastasis; thus, SPRY4-IT1 may be used as a therapeutic target (14).